ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Vranken Pommery Monopole

Vranken Pommery Monopole (VRAP)

11.60
0.00
(0.00%)
Closed April 25 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
11.60
Bid
11.60
Ask
11.70
Volume
1,261
11.60 Day's Range 11.80
11.50 52 Week Range 16.35
Market Cap
Previous Close
11.60
Open
11.60
Last Trade
63
@
11.6
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,952
Shares Outstanding
8,878,974
Dividend Yield
13.79%
PE Ratio
16.76
Earnings Per Share (EPS)
0.69
Revenue
341.89M
Net Profit
6.15M

About Vranken Pommery Monopole

Sector
Wine,brandy & Brandy Spirits
Industry
Wine,brandy & Brandy Spirits
Headquarters
Reims, Marne, Fra
Founded
-
Vranken Pommery Monopole is listed in the Wine,brandy & Brandy Spirits sector of the Euronext with ticker VRAP. The last closing price for Vranken Pommery Monopole was 11.60 €. Over the last year, Vranken Pommery Monopole shares have traded in a share price range of 11.50 € to 16.35 €.

Vranken Pommery Monopole currently has 8,878,974 shares outstanding. The market capitalization of Vranken Pommery Monopole is 103.00 € million. Vranken Pommery Monopole has a price to earnings ratio (PE ratio) of 16.76.

VRAP Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.2-1.6949152542411.811.8511.6104111.67476785DE
4-0.45-3.7344398340212.0512.1511.5226211.81661293DE
12-1.15-9.0196078431412.7512.8511.5295212.11845371DE
26-2-14.705882352913.613.911.5244312.54347522DE
52-3.7-24.183006535915.316.3511.5192613.46560632DE
156-5.9-33.714285714317.519.111.5194315.74885317DE
260-2.55-18.021201413414.1519.5511.5219715.94657859DE

VRAP - Frequently Asked Questions (FAQ)

What is the current Vranken Pommery Monopole share price?
The current share price of Vranken Pommery Monopole is 11.60 €
How many Vranken Pommery Monopole shares are in issue?
Vranken Pommery Monopole has 8,878,974 shares in issue
What is the market cap of Vranken Pommery Monopole?
The market capitalisation of Vranken Pommery Monopole is EUR 103M
What is the 1 year trading range for Vranken Pommery Monopole share price?
Vranken Pommery Monopole has traded in the range of 11.50 € to 16.35 € during the past year
What is the PE ratio of Vranken Pommery Monopole?
The price to earnings ratio of Vranken Pommery Monopole is 16.76
What is the cash to sales ratio of Vranken Pommery Monopole?
The cash to sales ratio of Vranken Pommery Monopole is 0.3
What is the reporting currency for Vranken Pommery Monopole?
Vranken Pommery Monopole reports financial results in EUR
What is the latest annual turnover for Vranken Pommery Monopole?
The latest annual turnover of Vranken Pommery Monopole is EUR 341.89M
What is the latest annual profit for Vranken Pommery Monopole?
The latest annual profit of Vranken Pommery Monopole is EUR 6.15M
What is the registered address of Vranken Pommery Monopole?
The registered address for Vranken Pommery Monopole is 5 PLACE GENERAL GOURAUD, B.P. 1049, REIMS, MARNE, 51100
What is the Vranken Pommery Monopole website address?
The website address for Vranken Pommery Monopole is www.vrankenpommery.com
Which industry sector does Vranken Pommery Monopole operate in?
Vranken Pommery Monopole operates in the WINE,BRANDY & BRANDY SPIRITS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALSENSensorion
0.2092 €
(34.53%)
2.23M
EBUSEbusco Holding NV
0.6485 €
(27.66%)
5.29M
MLFXOFinaxo
2.26 €
(19.58%)
808
MLSMLSmalto
0.015 €
(15.38%)
2k
ALLDLLDLC Groups
7.70 €
(14.93%)
24.07k
PHXMPHAXIAM Therapeutics SA
0.1515 €
(-73.88%)
234.8k
ALCHIAlchimie
0.231 €
(-42.25%)
365.3k
ALNEVNeovacs
0.013 €
(-23.08%)
3.18M
ALOKWGroupe Okwind SA
1.57 €
(-21.18%)
61.01k
MLNMAMiguet Et Associes
0.15 €
(-20.21%)
250
ALEUPEuroplasma
0.017 €
(11.11%)
326.62M
ALVERVergnet
0.0007 €
(0.00%)
294.39M
ALALOAcheterLouerFR
0.0004 €
(-20.00%)
270.92M
ALHPIHopium SA
0.0009 €
(-10.00%)
109.33M
BCPBanco Comercial Portugues SA
0.5684 €
(1.97%)
57.02M

Discussion

View Full Feed
northam43 northam43 6 minutes ago
SPX Daily Chart.

https://investorshub.advfn.com/uimage/uploads/2025/4/25/ajulc1.1_Updates.PNG

https://investorshub.advfn.com/uimage/uploads/2025/4/25/gzkteDaily_Chart.png
PatB1 PatB1 6 minutes ago
That would give me a chance to get out of this train wreck!
TONR
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 7 minutes ago
Questions for AGM
1. What is status of EMA filing, how fast will any questions be answered by AVXL
2. Will FDA filing proceed after EMA questions answered.
3. Any serious partnership discussions? Parameter of a deal AVXL is seeking?
4. PD trial?
5. Rett filing?.
AVXL
SkyLimit2022 SkyLimit2022 7 minutes ago
Gro,

Yes, NWBO’s platforms are INCREDIBLE, and additional clinical data are being collected today and will continue to be gathered moving forward…

https://investorshub.advfn.com/uimage/uploads/2025/4/25/tfmyjgiphy.gif

BP is starting to recognize the “incr
NWBO PII
MightyX MightyX 7 minutes ago
Looking AH setting up Monday new-52wk high close
UPXI
TenKay TenKay 7 minutes ago
And yet…price goes nowhere, more sells than buys, mediocre volume, and very very few of those bids seem to want to cross the fence by even one tick and slap dat ask.

LOL.

It’s flippers looking for a few tick flip…not anyone that will hold very long at all.
HMBL
MITIman007 MITIman007 7 minutes ago
After 2022, that was my sell signal.
MDCE
northam43 northam43 7 minutes ago
SPX Daily Chart.

https://investorshub.advfn.com/uimage/uploads/2025/4/25/ajulc1.1_Updates.PNG

https://investorshub.advfn.com/uimage/uploads/2025/4/25/gzkteDaily_Chart.png
vlispxpert vlispxpert 7 minutes ago
Well, keep eye out for "zone" picks, they're almost guaranteed winners...I'm even amazed at how they bounce almost every time they hit the "zone" ;)
Aquahoya Aquahoya 7 minutes ago
They just give shares to the lender. This will happen a lot until they cool off.
PSWW
Galzus Research Galzus Research 8 minutes ago
It's really hard to say. But a control group will be required if it's going to be like any of the other confirmatory trials.

Granted, some of those randomized confirmatory trials have been moving things into a different disease setting. Like tucatinib-trastuzumab in HER2-positive CRC
NWBO
mrkirby mrkirby 9 minutes ago
You can't argue with results.
SAPX
81vette 81vette 10 minutes ago
You nailed BULL to the wall bro! Excellent calls
LandPro LandPro 10 minutes ago
Yes, pay attention folks to what this Ashold is lying about. We all know what his agenda is. Lying and telling fairy tale is his MO.
RDAR
capgain capgain 10 minutes ago
Otis Taylor - Hey Joe - Must see photos.

https://www.youtube.com/watch?v=woaX1ImmpDE
StayHumble StayHumble 10 minutes ago
💹wow Xpert $GNCP BUYS+ info wow ✅💹✅💹 https://gncc-capital.com/Properties.html
GNCP
gimmegimmeminemine gimmegimmeminemine 10 minutes ago
They gotta be pretty damn close by now
Hopes and dreams
Maybe
Maybe not
Who knows?
I dont think so.
Not this batch or in a few weeks.
Hell, do we even know if he will PR it ?
Why would he? I mean it would be the starting point of the first
KBLB
Galzus Research Galzus Research 11 minutes ago
What's the point of responding if you don't have anything to add?
NWBO
bigfart bigfart 11 minutes ago
That was then now is a different catalyst
TSLA
hedge_fun hedge_fun 11 minutes ago
Any word on the “updated permitting” they’re……

waiting on?
SFRX
madras50 madras50 11 minutes ago
anyone know what the short position on this is? Possible for a major squeeze?
WW
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 12 minutes ago
Mike, up 4.79%, short interest declined

not a schitty week for a change
AVXL